Utilization of high throughput mechanical screening for the evaluation of mechanical properties and compressive injury models  by Mohanraj, B. et al.
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S233“Result window” shows the cartilage information with gray (or color)
intensity over the 3D bone shape. The developed program can display
and save color DICOMMRI as shown in Fig. 2, and provide the statistical
information (Mean, Min, Max of thickness and Volume) of the local VOI
of “Lateral Condyle” and “Medial Condyle” as shown in the ﬁgures.
Conclusions: This paper proposes fully automatic cartilage segmenta-
tion and measurement method without any training process. The
proposed method can visualize the whole cartilage distribution with
the 3D bone shape. The experimental results demonstrate that it can be
used for inspecting cartilage damage or loss directly. The developed
software is therefore applicable in clinical knee OA diagnosis systems.
Future studies include more tests with newMRI data for conﬁrming the
accuracy of the measurements.(Acknowledgment: This study was
supported by a grant of the Korean Health Technology R&D project,
Ministry for Health, Welfare & Family Affairs, and Republic of Korea.
(A091120))
Fig. 1. Cartilage segmentation and measuring software for diagnosis of knee OA
(gray).
Fig. 2. Cartilage segmentation and measuring software for diagnosis of knee OA
(color).
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LITHIUM CHLORIDE - A NOVEL TREATMENT FOR OSTEOARTHRITIS?
T. Minashima, Y. Zhang, Y. Lee, T. Kirsch. NYU Langone Med. Ctr., New
York, NY, USA
Purpose: Lithium chloride (LiCl) is currently being used for the treat-
ment of bipolar disorder because of its ability to interact with various
receptors and affect major signaling pathways. In addition, it has been
suggested that LiCl may inhibit matrix metalloprotease (MMP)expression in interleukin (IL)-1-treated articular chondrocytes. Based
on its ability to modulate signaling pathways, we hypothesized that LiCl
inhibits cartilage degradation during osteoarthritis (OA). Therefore, the
purpose of this study was to determine the effects and mechanism of
action of LiCl on cartilage degradation during OA.
Methods: The expression of catabolic genes and the activation of NF-kB
in mouse and human articular chondrocytes cultured in the absence or
presence of 10ng / ml IL-1, 50ng / ml IL-6, 10mM LiCl, and 10mM
glycogen synthase kinase 3 (GSK-3) inhibitor SB-216763 (SB) were
determined by real time PCR and luciferase reporter assays. Cell lysates
from chondrocytes treated with IL-1, IL-1 / LiCl, or IL-1 / SB were
analyzed for mitogen activated protein kinase (MAPK) and signal
transducer and activator of transcription 3 (STAT3) activities by
immunoblotting. Cartilage degradation in mouse femoral head explants
cultured in the absence or presence of IL-1, LiCl and SB was determined
by safranin O staining, and measuring the release of glycosaminoglycan
(GAG) and IL-6 into the culture media by ELISA. Cartilage degradation in
a post-traumatic OA mouse model using the transection of the medial
collateral ligament and partial medial meniscetomy (PMX) after treat-
ment with vehicle or LiCl (weekly intraarticular injections for 8 weeks)
was analyzed histologically by toluidine blue staining.
Results: Cartilage degradation was markedly reduced in LiCl-treated
mice 8 weeks after PMX surgery compared with vehicle-treated mice
despite the fact that Li+ as a potent inhibitor of GSK-3 stimulates Wnt/b-
catenin signaling, a well-known signaling pathway that stimulates
cartilage degradation in surgical-induced mouse OA models. To deter-
mine the mechanisms of how LiCl protects articular cartilage against
degradation, we determined the effects of LiCl and the GSK-3 inhibitor
(SB) on catabolic events in IL-1-treated mouse articular chondrocytes.
Treatment with LiCl, but not SB, resulted in decreased mRNA levels of
catabolic markers, including ADAMTS-5, COX-2, IL-6, iNOS, and MMP-13,
in articular chondrocytes treated with IL-1. LiCl markedly reduced the
proteoglycan loss and the release of IL-6 in IL-1-treated mouse articular
chondrocytes or femoral head explants, whereas SB further increased
proteoglycan loss and IL-6 release in IL-1-treated chondrocytes or
explants. LiCl treatment markedly reduced NF-kB and p38 MAPK
signaling activities in IL-1-treated chondrocytes. As a consequence of
reduced IL-6 expression in LiCl and IL-1-treated chondrocytes, LiCl
markedly reduced Jak/STAT3 signaling activity in IL-1-treated chon-
drocytes. LiCl directly reduced Jak/STAT3 signaling activity in IL-6-treated
articular chondrocytes.
Conclusion: LiCl protects articular cartilage against degradation during
OA via the inhibition of major signaling pathways involved in OA
pathology, including NF-kB, p38 MAPK and STAT3 signaling. Our ﬁnd-
ings suggest that LiCl as a modulator of the activities of major signaling
pathways involved in OA pathology may act as novel compound for the
treatment of OA. The advantage of LiCl as a potential novel compound
for the treatment of OA is that LiCl is already approved for the treatment
of patients with bipolar disorders.
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UTILIZATION OF HIGH THROUGHPUT MECHANICAL SCREENING FOR
THE EVALUATION OF MECHANICAL PROPERTIES AND COMPRESSIVE
INJURY MODELS
B. Mohanraj, C. Hou, M. Schmidt, R.L. Mauck, G.R. Dodge. Univ. of
Pennsylvania, Philadelphia, PA, USA
Purpose: Restoration of cartilage after damage remains a perplexing
clinical issue. High throughput (HT) assays enable rapid screening of
chemical libraries for the discovery of novel compounds relevant to
tissue development and healing. For musculoskeletal tissue engi-
neering applications, HT technologies should also enable measurement
of construct mechanical properties, as the success of these repair
therapies will likely depend on their mechanical functionality. Similarly,
given the mechanical origin of certain diseases, such as post-traumatic
osteoarthritis (PTOA), HT methods for mechanical perturbation of
numerous constructs might prove beneﬁcial for the identifying novel
factors that modulate disease progression. Here we demonstrate that
a novel HT mechanical screening (HTMS) device can enable measure-
ment of compressive mechanical properties of biomaterials and induce
reproducible injury in engineered cartilage in a HT manner.
Methods: HTMS Testing of Hydrogels: 15% polyacrylamide (PA) and 4%
agarose (Ag) gels (Ø:4mm,H:2.25mm; n¼24/material) were tested
using a step-compression protocol in the 48 well device. Gels were
compressed to 10% strain over 200s and held for 1000s per step, for
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height; only the ﬁrst full step was used to calculate the equilibrium
modulus. HTMS results were compared to single Instron tests to
determine the accuracy of the device. Injury: Cartilage analogs (CTAs:
scaffold-less bovine chondrocytes) were individually compressed to
75% or 50% strain at 50% strain/s and harvested 12, 24, and 120 hrs post-
trauma. Subsequently, the HTMS device was used to compress
constructs to 60% strain at 50%/s, with harvest at 24 and 120hrs.
Outcome assays: DMMB to measure construct and soluble GAG; Griess
to measure nitric oxide (NO); and RT-PCR to ECM and protease gene
expression. Live/Dead imaging and Alcian blue staining (proteoglycans)
were used to visualize cell death and matrix loss after injury.
Results: HTMS: The HTMS device reliably and accurately measured the
compressive mechanical properties of both 15% PA and 4% Ag gels (Fig
1B). Both the mean and standard deviation of HTMS versus Instron
measured Young's moduli were similar. Speciﬁcally, the HTMS-derived
EY of 15%PA was 83.4+/-27.5 kPa and of 4%Ag was 49.4+/-12.2 kPa,
which was not signiﬁcantly different from the Instron EY of 79.8+/-15.5
kPa and 43.3+/-9.5 kPa, respectively. These results illustrate that the
device can determine differences between construct populations as
small as w30kPa (Fig 1A).
Figure 1. - Testing of multiple samples in the HTMS device. (A) Equilibrium modulii of
15% Polyacrylamide and 4% Agarose gels measured using the HTMS device (HTMS:
n¼24/group) shows signiﬁcant differences between the two (p<0.0001, unpaired t-
test) (B) Quantitative comparisons between high throughput (HTMS) and sample-by-
sample (Instron) analysis demonstrate the reliability of the device and similarity of
variances (Instron: n¼3/group).
Injury: The catabolic response to injury was strain-dependent, as evi-
denced by NO release (Fig 2A). Nitrite concentrations peaked at 24 hrs
for both strain levels, and was signiﬁcantly higher for 75% compared to
50% strain. Similarly, NO peaked at 24 hrs following HTMS injury (Fig
2B). Live/Dead imaging showed cell death predominantly in areas
adjacent to ﬁssures in the tissue, while Alcian blue staining showed loss
of PG in these damaged areas (Fig 2C).
Figure 2. (A) Preliminary results evaluating several injurious compression impact
protocols on CTAs. Nitrite release to the media at 12, 24, and 120 hours post injury
show strain-dependent level of induced injury. p<0.0S * vs 50 and 75% strain and $ vs
75% strain (same time point); @ vs other time points. Nitrite is a by-product of nitric
oxide which is a key molecule that mediates inﬂammatory processes, (B) Preliminary
results evaluating injurious compression applied using the HTMS device. Similartrends in nitrite are observed as in single impact tests. p<0.05 * vs control at 24 hrs. (C)
Live/Dead and Alcian Blue staining of impacted CTAs from HTMS tests show cell death
and ﬁssure formation post-impact.
Conclusions: HTMS approaches can serve as valuable tools for inves-
tigating the development of mechanical properties in engineered
cartilage, as well as the mechanisms governing the chondrocyte
response after injury in PTOA. Our device can evaluate and distinguish
between the properties of two hydrogels, reliably and accurately rela-
tive to traditional lower throughput methods. In addition, we can
induce catabolic responses following injury in engineered cartilage,
which parallels studies of osteochondral explants. Future studies will
evaluate mediators that could control the inﬂamasone after injury and
screen small molecule libraries for therapeutics critical to advancing
PTOA therapy.
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A SYSTEMS BIOLOGY APPROACH IDENTIFIES HEPARIN-BINDING EGF-
LIKE GROWTH FACTOR AS A POTENTIAL MEDIATOR IN OA
R.F. Loeser y, D.L. Long y, A.L. Olex z, J.S. Fetrow z. yWake Forest Sch. of
Med., Winston-Salem, NC, USA; zWake Forest Univ., Winston-Salem, NC,
USA
Purpose: In order to discover novel mediators that may play a role in
OA, we used computational modeling of gene expression microarray
data to determine pathways regulated during the development of OA in
mice. From this analysis, we chose heparin-binding EGF-like growth
factor (HB-EGF) for further functional studies.
Methods: 12 week-old male C57/BL6 mice underwent surgical desta-
bilization of the medial meniscus (DMM) to induce OA or sham surgery
as control. Joint tissues were collected for isolation of RNA (n¼9 mice
per surgical group per time point) pre-surgery (time 0) and at 2, 4, 8,
and 16 weeks after surgery. RNA used for microarrays and real-time PCR
was isolated from pooled joint tissue collected from the medial side of
the joint, including cartilage, meniscus, subchondral bone, and joint
capsule with synovium. Genes passing a detection ﬁlter, SLR ﬁlter (0.5
or-0.5 for at least one time point in all 3 pools), and a consistency ﬁlter
were used for computational modeling. The gene expression data was
overlaid on a protein-protein interaction network extracted from the
Kyoto Encyclopedia of Genes and Genomes (KEGG) and then jActive-
Modules (JAM) was used to identify sub-networks that were signiﬁ-
cantly regulated at the various time points in the DMMmice relative to
sham controls. From this analysis, HB-EGF was selected for further
study by immunohistochemistry and by in vitro stimulation studies
using cultured human articular chondrocytes. Effects of recombinant
HB-EGF,  recombinant ﬁbronectin fragments (FN-F), on MMP-13
production were measured by immunoblotting and real time (RT)-PCR
and on Rac activity using an activity assay.
Results: A total of 427 genes passed the consistency and signiﬁcance
ﬁlters. JAM analysis revealed 13 subnetworks from the changes in gene
expression activity during the time course where the majority of up-
regulated genes were up at 2 and 4 weeks after DMM surgery. The
largest subnetwork included several collagens, syndecans, ﬁbronectin,
thrombospondins, TGFb family members, HIF1a and HIF2a, EGF and
PDGF family members, HB-EGF, and MMP-2 (Fig.1). Because it had not
been previously studied in OA and was located at a key point in the
subnetwork, we chose HB-EGF for further analysis. Immunohisto-
chemical staining revealed increased HB-EGF in human OA cartilage
relative to age-matched normal (n¼4 each). Treatment of cultured
human chondrocytes, isolated from normal cartilage, with the catabolic
stimulus FN-f increased HB-EGF expressionwhich peaked at almost 60-
fold (by RT-PCR) at 3 hours. HB-EGF is a known ligand for the EGF
receptor (EGFR) which signals through MAP kinases and the small
GTPase Rac. We found that HB-EGF at 10ng/ml stimulated chondrocyte
Rac activity and phosphorylation of the EGFR, ERK and p38 but not JNK.
High dose (100ng/ml) but not low dose (10ng/ml) HB-EGF stimulated
MMP-13 production in conditioned media, detected by immunoblot-
ting. However, low dose HB-EGF enhanced the MMP-13 production
induced by FN-F by 1.4-fold over FN-f alone and this was completely
inhibited by blocking Rac1 with 100mMNSC23766 or EGFR with 250 nM
AG1478.
Conclusions: An unbiased computational modeling approach discov-
ered that a subnetwork containing HB-EGF was upregulated at early
time points (2 and 4 weeks) in the DMM model of OA. One mechanism
may be the increased formation of FN-fs, known to be present in OA
